Nektar Therapeutics (NASDAQ:NKTR)

0.7745
Delayed Data
As of 3:59pm ET
 +0.0565 / +7.87%
Today’s Change
0.71
Today|||52-Week Range
6.26
-65.73%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Zalevsky Jonathan
Chief Research & Development Officer
Sale8/18/202273,716$4.65$342.8K-84.66%
Robin Howard W
President & Chief Executive Officer
Sale5/16/202236,529$3.95$144.3K-81.49%
Robin Howard W
President & Chief Executive Officer
Sale11/16/202238,014$3.57$135.7K-79.60%
Zalevsky Jonathan
Chief Research & Development Officer
Sale5/16/202221,673$3.95$85.6K-81.49%
Eastham Karin
Director
Sale9/13/202221,267$3.61$76.8K-79.77%
Labrucherie Gilbert M
Chief Operating & Financial Officer & Senior VP
Sale5/16/202217,448$3.95$68.9K-81.49%
Robin Howard W
President & Chief Executive Officer
Sale8/16/202213,759$4.76$65.5K-84.66%
Robin Howard W
President & Chief Executive Officer
Sale2/16/202319,635$3.00$58.9K-75.91%
Zalevsky Jonathan
Chief Research & Development Officer
Sale8/16/202210,560$4.76$50.3K-84.66%
Zalevsky Jonathan
Chief Research & Development Officer
Sale11/16/202213,460$3.57$48.1K-79.60%
Page of 4